Bariatric Surgery Improves Metabolic and Non-Alcoholic Fatty Liver Disease Markers in Metabolically Healthy but Morbidly Obese Patients At 5 Years

No studies have evaluated the effect of metabolic and bariatric surgery (MBS) on non-alcoholic fatty liver disease (NAFLD) and cardiometabolic markers in metabolically-healthy morbidly-obese (MHMO) patients at mid-term.

Source: Surgery for Obesity and Related Diseases - August 11, 2021 Category: Surgery Authors: Alberto Goday, Helena Juli à, Aleix de Vargas-Machuca, Juan Pedro-Botet, Sergi Benavente, Jose M. Ramon, Manuel Pera, Anna Casajoana, Montserrat Villatoro, Laia Fontané, Maria Bisbe, Elisenda Climent, Olga Castañer, Juana A. Flores Le Roux, David Benai Tags: Original articles Source Type: research